Circassia Pharmaceuticals PLC | |
Stock Exchange | London Stock Exchange |
EPS |
GBP0.34 |
Market Cap |
GBP73.42 M |
Shares Outstanding |
375.14 M |
Public Float |
270.05 M |
Address |
Northbrook House Oxford Oxfordshire OX4 4GA United Kingdom |
Employees | - |
Website | http://circassia.com |
Updated | 07/08/2019 |
Circassia Pharmaceuticals Plc is a biopharmaceutical company, which engages in the development and commercialization of allergy, asthma, and respiratory products. It operates through the following segments: NIOX, Respiratory, and US AZ Collaboration. The NIOX segment provides a portfolio of products used to improve asthma diagnosis and management by measuring fractional exhaled nitric oxide. |